Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts



Status:Withdrawn
Conditions:Breast Cancer, Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:10/20/2017
Start Date:April 2001
End Date:December 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Characterization of Breast Masses Using a New Method of Ultrasound Contrast Agent Imaging in 3D Mapping of Vascular Anomalies

The purpose of this study is to determine if breast imaging with ultrasound can be improved
by using 1) a ultrasound attachment with two transducers and 2) a contrast agent. These
changes might allow smaller blood vessels to be seen than under the way breast ultrasound is
usually performed.

The purpose of this study is to determine if performing ultrasound with an attachment made up
of two transducers (rather than just a single transducer) will provide more information about
the blood vessels in the breast than the current attachment.

The study will also examine the question of whether use of an ultrasound contrast agent will
the scanner to see smaller blood vessels than are detected without the agent.

Inclusion Criteria:

- Female subjects who have breast masses and scheduled for core biopsy.

Exclusion Criteria:

- Pregnant or lactating females.

- Females who have heart problems or sensitivity to contrast agents.

- Females who have had previous surgery for breast cancer.
We found this trial at
1
site
University of Michigan Health System
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health System The University of Michigan is home to one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials